(0.07%) 5 252.10 points
(-0.06%) 39 735 points
(0.01%) 16 401 points
(1.34%) $82.44
(0.52%) $1.727
(1.79%) $2 229.80
(0.46%) $24.87
(1.36%) $922.10
(0.25%) $0.926
(0.57%) $10.83
(0.01%) $0.791
(-0.32%) $92.15
@ $44.72
Issued: 27 Mar 2024 @ 11:21
Return: -0.70%
Previous signal: Mar 26 - 15:44
Previous signal:
Return: 0.48 %
Live Chart Being Loaded With Signals
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy...
Stats | |
---|---|
Today's Volume | 81 825.00 |
Average Volume | 1.20M |
Market Cap | 6.47B |
EPS | $0 ( 2024-02-21 ) |
Next earnings date | ( $-1.110 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -17.34 |
ATR14 | $0.548 (1.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-26 | Jenne Kyle | Buy | 65 203 | Non-Qualified Stock Option (right to buy) |
2024-02-26 | Jenne Kyle | Sell | 0 | Common Stock |
2024-02-29 | Swayze Eric | Buy | 605 | Common Stock |
2024-02-29 | Monia Brett P | Buy | 538 | Common Stock |
2024-02-29 | Geary Richard S | Buy | 604 | Common Stock |
INSIDER POWER |
---|
55.80 |
Last 100 transactions |
Buy: 1 323 866 | Sell: 373 653 |
Volume Correlation
Ionis Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
ALVR | 0.928 |
BGFV | 0.913 |
GRNA | 0.902 |
INFI | 0.897 |
CARE | 0.895 |
CMCT | 0.893 |
GBCI | 0.889 |
EQ | 0.889 |
BIOC | 0.885 |
CRBU | 0.882 |
10 Most Negative Correlations | |
---|---|
STAY | -0.908 |
TRMD | -0.878 |
BCOR | -0.875 |
PAYA | -0.873 |
IBEX | -0.868 |
PDFS | -0.867 |
BNIXU | -0.866 |
TGLS | -0.865 |
LRFC | -0.865 |
ARDX | -0.861 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ionis Pharmaceuticals Inc Correlation - Currency/Commodity
Ionis Pharmaceuticals Inc Financials
Annual | 2023 |
Revenue: | $787.65M |
Gross Profit: | $778.51M (98.84 %) |
EPS: | $-2.56 |
Q4 | 2023 |
Revenue: | $324.51M |
Gross Profit: | $321.44M (99.06 %) |
EPS: | $-0.0643 |
Q3 | 2023 |
Revenue: | $144.00M |
Gross Profit: | $142.00M (98.61 %) |
EPS: | $-1.030 |
Q2 | 2023 |
Revenue: | $188.00M |
Gross Profit: | $185.00M (98.40 %) |
EPS: | $-0.600 |
Financial Reports:
No articles found.
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators